The Global Neurology Services Market Size is estimated to be worth US$ 2,562.8 billion by the end of 2022 and to grow at a 5.4% CAGR from 2022 to 2032. By 2032, the market is expected to be worth US$ 4,317.8 billion. The therapeutic services category leads the market by service, with a market share …
Category Archives: Healthcare Trends
Harnessing Technology | How Digital Stethoscopes Are Reshaping Medical Practice
The global Digital Stethoscope Market Size was worth US$ 93.18 million in 2022. The key growth drivers for the market are projected to be increased medical usage and a diverse variety of applications. Between 2022 and 2032, overall Digital Stethoscope sales are predicted to expand at a 5.7% CAGR, totalling roughly US$ 162.2 million by …
Continue reading “Harnessing Technology | How Digital Stethoscopes Are Reshaping Medical Practice”
Emerging Innovations and Rising Healthcare Investments Drive Growth in Dental Ceramics Market
During the projected period of 2022 to 2032, the worldwide Dental Ceramics Market Demand is expected to grow at a moderate rate of roughly 4.9% CAGR. The global market is now valued at US$ 339 million in 2022 and is expected to reach a peak of US$ 572 million by 2032. The market’s expansion can …
Knee Hyaluronic Acid Injections Market Achieves Impressive Revenue of US$ 2.09 Billion in 2023
According to the most recent insights by Future Market Insights survey, the knee hyaluronic acid injections market will generate US$2.09 billion in revenue in 2023. By 2033, sales of knee hyaluronic acid injections as a whole are projected to grow at a CAGR of 5% to reach US$ 3.40 billion. According to a recent study …
Oligonucleotide API Market Expected to Witness Significant Growth, Reaching US$ 5.36 Billion by 2030
The demand for oligonucleotide APIs is anticipated to increase from 2022 to 2030 at a high CAGR of 10.2% due to the growing need for new drug classes. As a result, it is anticipated that by the end of 2030, the global oligonucleotide API market will have grown from a valuation of US$ 2.46 billion …
Projected Surge in Veterinary Biologics Market: Estimated to Reach US$ 18.2 Billion by 2029
The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is expected to reach US$ 18.2 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Veterinary Biologics Market Outlook: Data Points Market Insights Market Value 2021 USD 10.6 Bn Market Value 2029 USD 18.2 Bn CAGR 2022-2029 6.9% Key Players The key …
Ultrasound Systems Market to Grow at 5.5% CAGR during Forecast Period (2022-2028): Industry Analysis and Future Projections
The market for ultrasound systems is expected to reach USD 13.2 Billion by 2028, growing at a CAGR of 5.5% over the forecast period, from an estimated USD 9.5 Billion in 2022. (2022-2028). Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just …
Cold, Cough, and Sore Throat Remedies Market to Expand at 0.6% CAGR between 2022 and 2032: Valued at Approximately US$ 37.7 Billion by 2032
By the end of 2022, the market for cold, cough, and sore throat remedies is anticipated to be worth US$ 39.9 Billion. From 2022 to 2032, the market is projected to grow at a CAGR of 0.6%, reaching a valuation of US$ 37.7 Billion. Future Market Insights’ latest report delivers such discernments that are expected to …
Promising Outlook for the Neurovascular Stent Retrievers Market: Growth at a CAGR of 6.3%, Projected to Reach US$ 1243.57 Million by 2032
The Neurovascular Stent Retrievers Market is a segment of the medical devices industry that focuses on devices used in the treatment of ischemic stroke. Ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, leading to a loss of blood flow and potentially causing brain damage. Neurovascular stent retrievers, also …
Future Prospects of Tamoxifen Market: Estimated Value of USD 687.44 Million by 2032 with a CAGR of 0.07%
The Tamoxifen Market is blocks the oestrogen receptor in breast tissue. This selective oestrogen receptor modulator is used to treat breast cancer. While operating as an antagonist in mammary tissue, tomoxifen acts as an agonist in the endometrium. Both men and women with metastatic breast cancer should take tamoxifen, according to medical advice. Additionally, ductal …